BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12475908)

  • 1. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
    Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
    FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
    J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
    Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
    Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
    Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
    Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis for ischemic syndromes.
    Weisz A; Koren B; Fischer L; Lewis BS; Flugelman MY
    Isr Med Assoc J; 2000 Jul; 2 Suppl():52-7. PubMed ID: 10909418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model.
    Gowdak LH; Poliakova L; Li Z; Grove R; Lakatta EG; Talan M
    J Vasc Surg; 2000 Aug; 32(2):343-52. PubMed ID: 10917995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
    Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
    Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
    Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
    Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in rabbit model of hind limb ischemia.
    Ishii S; Koyama H; Miyata T; Nishikage S; Hamada H; Miyatake S; Shigematsu H
    J Vasc Surg; 2004 Mar; 39(3):629-38. PubMed ID: 14981459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.
    Mack CA; Magovern CJ; Budenbender KT; Patel SR; Schwarz EA; Zanzonico P; Ferris B; Sanborn T; Isom P; Ferris B; Sanborn T; Isom OW; Crystal RG; Rosengart TK
    J Vasc Surg; 1998 Apr; 27(4):699-709. PubMed ID: 9576084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia.
    Wafai R; Tudor EM; Angus JA; Wright CE
    J Vasc Res; 2009; 46(1):45-54. PubMed ID: 18552506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle.
    Poliakova L; Kovesdi I; Wang X; Capogrossi MC; Talan M
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):339-47. PubMed ID: 10425008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
    Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
    Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia.
    Oda S; Nagahama R; Nakano K; Matoba T; Kubo M; Sunagawa K; Tominaga R; Egashira K
    J Vasc Surg; 2010 Aug; 52(2):412-20. PubMed ID: 20573471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
    Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K
    FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene.
    Tsurumi Y; Kearney M; Chen D; Silver M; Takeshita S; Yang J; Symes JF; Isner JM
    Circulation; 1997 Nov; 96(9 Suppl):II-382-8. PubMed ID: 9386128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.